Chantel Wilson Chase has worked in data science (quantitative and qualitative) roles in the Boston area for more than 25 years. She currently leads the Quality Analytics and Reporting division at Alexion, AstraZeneca Rare Disease Business Unit. With employee experience as the underlying foundation of all her work, she focuses on automation, investigations, and deep dive analysis to drive adoption and engagement forward. She holds a Master’s Degree in Applied Sociology and a Bachelor’s Degree in Actuarial Science/Mathematics.